TSLA — Tesla, Inc.
Tesla, Inc. operates globally, specializing in the creation, production, and distribution of electric vehicles, alongside comprehensive energy generation and storage solutions. Its market reach extends across the United States, China, and various other international regions.
Price chart & technical analysis
Loading chart…
As of 2026-09-13, TSLA traded at $365.44 with a $1.44T market cap, a 309.7x TTM P/E, and ~214x forward P/E on next-FY EPS of $1.705; RSI was 54.45 and the stock sat 8.39% below its 200-day SMA. Q2 2026 revenue grew 25.5% YoY to $28.24B, but operating margin compressed to 1.4% and free cash flow was -$1.09B.
As of 2026-09-13, sentiment was split: Q2 2026 delivered record volume and +25.5% YoY revenue, but EPS missed by ~33-39% and FCF turned negative by $1.09B, so the market is caught between core auto margin compression and Robotaxi/FSD/Optimus optionality. RSI at 54.45 and price 8.39% below the 200-day SMA reflect a range-bound, show-me tape ahead of the Oct 28 Q3 earnings.
Revenue has grown over three years but is seasonal and lumpy: Q2 2026 revenue of $28.24B was up 25.5% YoY from $22.50B in Q2 2025 and above Q3 2024's $25.18B. However, profitability has decelerated sharply: operating margin was 1.4% in Q2 2026 vs 4.1% in Q2 2025, 10.8% in Q3 2024, and 6.2% in Q4 2024; net income fell to $1.11B from $2.17B in Q3 2024. EPS of $0.32 in Q2 2026 was slightly below Q2 2025's $0.333 and far below Q4 2024's $0.658. This is a margin-compression story even as top-line growth reaccelerated—Q2 2026 is a recent blip lower in profitability, not yet a structural revenue decline, but the trend of earnings decoupling from deliveries is clear.
Expensive. As of 2026-09-13, TTM P/E was 309.7x, forward P/E ~214x on next-FY EPS of $1.705, P/S 13.9x vs 5yr avg 12.15x, P/B 13.6x, and EV/EBITDA 107x. The 5yr avg P/E of 166.75x applied to $1.705 yields only ~$284, well below the $365.44 price. Analyst consensus target of $471.33 implies ~276x forward P/E, so the stock is pricing in a dramatic autonomy/energy-driven margin recovery that has not yet appeared in reported results.
Price is discounting future earnings, not current ones. Q2 2026 EPS of $0.32 missed, but next-FY consensus EPS of $1.705 implies +44.6% growth, so the market is paying ~214x forward for that recovery. Even if EPS hits $1.705, the stock still trades at 214x—a multiple that requires either massive upward estimate revisions or a permanent re-rating. If margins merely stabilize at Q2 levels, the current price is hard to justify; if Robotaxi/FSD scales, the multiple could be absorbed. This is a binary narrative stock, not a normal earnings-multiple play.
As of 2026-09-13, RSI was 54.45 (neutral), price was 2.9% above the 20-day SMA and 3.09% above the 50-day SMA but 8.39% below the 200-day SMA. Short-term momentum improved (+11.58% 1mo, +3.21% 1wk), yet the 3mo return was -10.09% and 6mo -6.58%, so this looks like a countertrend bounce within a longer downtrend. Entry-timing implication: wait for a reclaim of the 200-day or a pullback toward $340-350; chasing the bounce into the Oct 28 earnings event carries elevated event risk.
- Higher-for-longer interest rates continue to pressure consumer financing for high-ticket EVs, limiting demand elasticity.
- Intensifying EV price competition, especially from BYD in China and Europe, forces Tesla to trade margin for volume.
- Regulatory and tariff headwinds: China's ~3M-vehicle recall, proposed 50% Canadian auto tariffs, and NHTSA scrutiny of autonomous-driving claims.
- Energy storage tailwind: surging AI data-center electricity demand supports Megapack/Powerwall deployments, a high-growth, higher-margin offset.
- Currency and commodity cost volatility, plus supply-chain localization requirements, add margin uncertainty.
- Q3 2026 earnings on Oct 28, 2026: focus on automotive gross margin stabilization and energy storage deployment growth.
- Robotaxi/Cybercab regulatory approvals and commercial scaling in key U.S. states like California and Texas.
- European FSD Supervised expansion (Slovenia was the sixth country to approve) and potential software monetization.
- Optimus humanoid robot commercial pilot or manufacturing scale-up timeline.
- Any new lower-cost model announcement or production ramp that could revive auto volume/margin mix.
- Continued auto margin compression and negative free cash flow if price cuts persist and capex stays elevated (Q2 2026 FCF -$1.09B).
- Extreme valuation: ~214x forward P/E leaves no margin of safety for execution missteps.
- Competitive share loss to BYD and other low-cost EV makers, especially in China and Europe.
- Regulatory/legal setbacks: recalls, NHTSA autonomy scrutiny, tariffs, and potential forced software changes.
- Autonomy and Optimus timelines slipping, which would remove the primary support for the premium multiple.
At $365.44 as of 2026-09-13, Tesla is not a clean buy. The core auto business is barely profitable—Q2 2026 operating margin 1.4%, ROIC 3%, FCF -$1.09B—while the stock trades at ~214x forward earnings. The bull case rests on energy storage and autonomy, which are real but early and unproven at scale. I'd want either a lower entry (closer to $340-350) or evidence of margin stabilization before getting constructive; existing holders can justify holding for optionality with disciplined position sizing, but new money is paying a rich price for a narrative.
Applied a 205x forward P/E to next-FY consensus EPS of $1.705. That multiple is a ~23% premium to Tesla's 5-year average P/E of 166.75x, justified by energy storage and autonomy optionality, but below the current ~214x forward P/E and the analyst-implied ~276x to reflect compressed auto margins (Q2 2026 operating margin 1.4%) and negative FCF. 205 × $1.705 = $349.53.
The deterministic score of 72.8 ('Good Fundamentals') fairly captures Tesla's strong revenue growth (+25.5% YoY in Q2 2026), healthy balance sheet (D/E 0.108, current ratio 1.94), and negative accruals ratio (-2.41%), which is a genuine cash-quality positive. But it over-weights the 77.7 ratio screener and 84.4 growth leg while under-weighting the fact that Q2 2026 operating margin was just 1.4%, ROIC 3%, and FCF was -$1.09B. The 'Rich vs. its own history' valuation label is correct: ~214x forward P/E and 13.9x P/S leave little room for error. I'd move the score down to the low-to-mid 60s, i.e., Fair rather than Good Fundamentals, making this a valuation- and execution-sensitive story rather than a clean compounding setup.
AI-generated analysis for informational purposes only, not financial advice.